Utilization of Echocardiography After Acute Kidney Injury Was Associated with Improved Outcomes in Patients in Intensive Care Unit

We aimed to investigate the association between usage of transthoracic echocardiography (TTE) within 24 hours after acute kidney injury (AKI) and the prognosis of patients in intensive care unit (ICU). The Medical Information Mart for Intensive Care III (MIMIC-III) database was used to identify AKI...

Full description

Saved in:
Bibliographic Details
Published in:International journal of general medicine 2021-01, Vol.14, p.2205-2213
Main Authors: Hu, Yugang, Zhou, Jia, Cao, Quan, Wang, Hao, Yang, Yuanting, Xiong, Ye, Zhou, Qing
Format: Article
Language:English
Subjects:
acute kidney injury
Cardiovascular disease
Chronic obstructive pulmonary disease
Clinical outcomes
Creatinine
Echocardiography
Intensive care
Kidney diseases
Mediation
medical information mart for intensive care
Medical prognosis
Mortality
Original Research
Performance evaluation
propensity score matching
Renal replacement therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We aimed to investigate the association between usage of transthoracic echocardiography (TTE) within 24 hours after acute kidney injury (AKI) and the prognosis of patients in intensive care unit (ICU). The Medical Information Mart for Intensive Care III (MIMIC-III) database was used to identify AKI patients with and without TTE administration. The primary outcome was 28-day mortality. Multivariable regression was used to clarify the association between TTE and clinical outcomes and propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) were utilized to validate our findings. Among 23,945 eligible AKI patients, 3361 patients who received TTE and 3361 who did not conduct TTE had similar propensity scores which were included in this study. After matching, the TTE group had a significantly lower 28-day mortality (OR 0.80, 95% CI 0.72-0.88, P
ISSN:1178-7074
1178-7074
DOI:10.2147/IJGM.S310445